Search results for "arthralgia"

showing 10 items of 24 documents

Clinical and echographical control protocol of haemarthrosis in haemophilia patients with inhibitors: evaluation of the efficacy of recombinant facto…

2008

Summary.  The intention of the ‘clinical and echographical protocol of evaluation the efficacy of recombinant activated factor VII in the haemarthrosis’ (EFFISEVEN protocol) was to provide an extensive study of the evolution of haemarthrosis, and second, of its repercussions on the degenerative process of joints. The clinical evaluation of haemarthroses and their evolution is based on a well-established methodology, although very few studies have sought to determine the correlation between pain, mobility and the objective data regarding the haemorrhage. We believe that it is necessary to unify criteria and that the EFFISEVEN protocol may contribute data that improve standards which, in turn…

Adultmedicine.medical_specialtyTime FactorsAdolescentObjective dataFactor VIIaHemophilia AHaemophiliaDrug Administration ScheduleYoung AdultClinical ProtocolsHemarthrosisActivated factor VIIHumansMedicineRange of Motion ArticularIntensive care medicineGenetics (clinical)UltrasonographyProtocol (science)Blood Coagulation Factor Inhibitorsbiologybusiness.industryObjective methodHematologyGeneral Medicinemedicine.diseaseArthralgiaBlood Coagulation FactorsRecombinant ProteinsPatient managementEuropeRecombinant factor VIIaQuality of Lifebiology.proteinPhysical therapyBlood Coagulation TestsbusinessClinical evaluationHaemophilia
researchProduct

Radiofrequency Ablation for Chronic Lumbar Zygapophyseal Joint Pain Using a V-Shaped Active Tip Needle: An Observational Retrospective Study

2023

Giuliano Lo Bianco,1,2 Giovanni Misseri,2 Agnes R Stogicza,3 Gregoretti Cesare,2,4 Sean Li,5 Miles Day,6 David J Kennedy,7 Michael E Schatman8,9 1Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy; 2Anesthesiology and Pain Department, Fondazione Istituto “G. Giglio”, Cefalù, Palermo, Italy; 3Anesthesia and Pain, Saint Magdolna Private Hospital, Budapest, Hungary; 4Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Palermo, Italy; 5National Spine and Pain Centers, Shrewsbury, NJ, USA; 6Pain Research, The Pain Center at Grace Clinic, Texas Tech University HSC, Lubbock, TX, USA; 7Department of PM&R, V…

Anesthesiology and Pain Medicinepain managementneuromodulationradiofrequency ablationarthralgialumbar facet jointJournal of Pain Researchchronic painzygapophyseal jointJournal of Pain Research
researchProduct

Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients

2019

One of the most common adverse events (AEs) occurring during treatment with aromatase inhibitors (AIs) is musculoskeletal pain. The aim of our study was to analyze the influence of preexisting muscle/limb pain and joint pain on the development of AI-induced musculoskeletal AEs. Women eligible for upfront adjuvant endocrine therapy with letrozole were included in the PreFace study, a multicenter phase IV trial. During the first treatment year, they were asked to record musculoskeletal AEs monthly by answering questions regarding pain symptoms and rating the pain intensity on a numeric rating scale from 0 (no pain) to 10 (very strong pain). Pain values were compared using nonparametric statis…

Cancer Researchmedicine.medical_specialtyTime Factorsmedicine.drug_classMedizinBreast Neoplasms03 medical and health sciences0302 clinical medicineBreast cancerMusculoskeletal PainInternal medicinemedicineHumansIn patientAdverse effectAgedPain MeasurementEarly breast cancerAromatase inhibitorAromatase Inhibitorsbusiness.industryLetrozoleSignificant differenceMiddle Agedmedicine.diseaseArthralgiaPostmenopauseOncology030220 oncology & carcinogenesisJoint painLetrozoleFemalemedicine.symptombusinessmedicine.drugInternational Journal of Cancer
researchProduct

Complete Clinical Remission after High-Dose Immune Suppression and Autologous Hematopoietic Stem Cell Transplantation in Severe Crohn’s Disease Refra…

2004

Crohn's diseaseautologous hematopoieticbusiness.industrymedicine.medical_treatmentGastroenterologyHematopoietic stem cell transplantationmedicine.diseasearthritiImmune systemRefractoryMultiple SclerosiImmunologyautologous hematopoietic stem cell transplantationmedicineImmunology and AllergyarthralgiabusinessInflammatory Bowel Diseases
researchProduct

Validation of the German version of the Kujala score in patients with patellofemoral instability : a prospective multi-centre study

2017

Introduction: The Kujala score is the most frequently used questionnaire for patellofemoral disorders like pain, instability or osteoarthritis. Unfortunately, we are not aware of a validated German version of the Kujala score. The aim of our study was the translation and linguistic validation of the Kujala score in German-speaking patients with patella instability and the assessment of its measurement characteristics. Materials and methods: The German Kujala score was developed in several steps of translation. In addition to healthy controls, the Kujala German was assessed in consecutive patients undergoing reconstruction of the medial patellofemoral ligament for recurrent patellar dislocat…

Joint Instabilitymedicine.medical_specialtyKnee JointpolvetkyselytutkimussijoiltaanmenoMedial patellofemoral ligamentLinguistic validationSeverity of Illness IndexPatellofemoral pain syndrome (PFPS)GermanPatellofemoral Joint03 medical and health sciences0302 clinical medicineQuality of lifeCronbach's alphaSurveys and QuestionnairesValidationmedicineHumansOrthopedics and Sports Medicine030222 orthopedicsQuestionnairebusiness.industryKujala scorequestionnairepatellofemoral instabilityDiscriminant validityoireyhtymätkipu030229 sport sciencesGeneral MedicinePatellofemoral instabilityArthralgiaKujala patellofemoral scorelanguage.human_languageArthroscopy and Sports Medicinemedicine.anatomical_structureConvergent validityvalidointiLigaments ArticularOrthopedic surgerylanguagePhysical therapySurgerybusiness
researchProduct

Effects of whole-body vibration exercise on muscular strength and power, functional mobility and self-reported knee function in middle-aged and older…

2013

Abstract Background Whole-body vibration training using vertical-vibration machines is called “acceleration training” (AT). The purpose of this study was to elucidate the effect of AT on lower-limb muscular strength and power, functional mobility and self-reported knee function in middle-aged and older Japanese women with knee pain. Methods Thirty-eight middle-aged and older Japanese women (aged 50–73 years) with knee pain were divided into two groups: (1) the AT group (n = 29) engaged in AT three times per week for eight weeks, and (2) the control group (C group, n = 9). The AT program consisted of flexibility training, strength training of mainly the quadriceps and surrounding muscles and…

Knee functionmedicine.medical_specialtyKnee JointStrength trainingIsometric exerciseOsteoarthritisPhysical strengthVibrationVibratory stimulusPhysical medicine and rehabilitationAsian PeoplemedicineWhole body vibrationHumansOrthopedics and Sports MedicineMuscle StrengthProspective StudiesExercisePhysical Therapy ModalitiesAgedbusiness.industryta3141Resistance TrainingMiddle AgedOsteoarthritis Kneemedicine.diseaseArthralgiaExercise TherapyKnee painPhysical therapyFemaleSelf Reportmedicine.symptombusinesshuman activitiesThe Knee
researchProduct

Are changes in pain, cognitive appraisals and coping strategies associated with changes in physical functioning in older adults with joint pain and c…

2019

Background As the population ages, the number of people with chronic diseases increases. Frequently, older people suffer from joint pain together with other chronic diseases, which can lead to decreased physical functioning. Aims To investigate the associations of the changes in cognitive appraisals, coping strategies and pain with the change in physical functioning in older people, who have chronic pain and chronic diseases. Methods Elderly persons (n = 407, mean age 77 years, and 62% female), with self-reported joint pain and at least two chronic diseases, filled in questionnaires about cognitive appraisals, coping strategies, pain intensity and physical functioning at baseline, at 6- and…

MaleAgingPopulationfyysinen toimintakykyComorbiditycoping strategiesGee03 medical and health sciences0302 clinical medicineCognitionPhysical functioningAdaptation PsychologicalMedicineHumans030212 general & internal medicineeducationkrooniset tauditGeneralized estimating equationolder adultsAgedcognitive appraisalseducation.field_of_studybusiness.industryselviytyminenChronic painkipuCognitionPhysical Functional Performancemedicine.diseaseComorbidityArthralgiaJoint painChronic Diseasekrooninen kipuFemaleGeriatrics and Gerontologymedicine.symptombusiness030217 neurology & neurosurgeryikääntyneetClinical psychologyAging Clinical and Experimental Research
researchProduct

Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis

2020

Made available in DSpace on 2021-06-25T10:38:01Z (GMT). No. of bitstreams: 0 Previous issue date: 2020-11-01 Healthway Objective. To develop a composite disease activity score for systemic JIA (sJIA) and to provide preliminary evidence of its validity. Methods. The systemic Juvenile Arthritis Disease Activity Score (sJADAS) was constructed by adding to the four items of the original JADAS a fifth item that aimed to quantify the activity of systemic features. Validation analyses were conducted on patients with definite or probable/possible sJIA enrolled at first visit or at the time of a flare, who had active systemic manifestations, which should include fever. Patients were reassessed 2 wee…

MaleClinical assessment; Composite disease activity score; Disease activity; Outcome measures; Pediatric rheumatology; Still's disease; Systemic juvenile idiopathic arthritismedicine.medical_specialtyFeverClinical assessmentComposite disease activity scoreArthritisLymphadenopathyDiseaseSeverity of Illness IndexOutcome measuresOutcome measureJuvenile Arthritis Disease Activity ScoreRheumatologyCronbach's alphaSystemic juvenile idiopathic arthritisInternal medicineStill's diseaseContent validityMedicineJuvenileHumansPharmacology (medical)Pediatric rheumatologyDisease activityRange of Motion ArticularChildPain MeasurementSerositisThrombocytosisbusiness.industryConstruct validityReproducibility of ResultsAnemiaExanthemamedicine.diseaseArthralgiaRheumatologyArthritis JuvenileChild PreschoolSplenomegalyQuality of LifeFemaleHyperferritinemiabusinessHepatomegaly
researchProduct

Longterm Retention of Tumor Necrosis Factor-α Inhibitor Therapy in a Large Italian Cohort of Patients with Rheumatoid Arthritis from the GISEA Regist…

2012

Objective.To evaluate 4-year retention rates of tumor necrosis factor-α (TNF-α) inhibitors adalimumab, etanercept, and infliximab among patients with longstanding rheumatoid arthritis (RA), as derived from an Italian national registry.Methods.The clinical records of 853 adult patients with RA in the GISEA (Gruppo Italiano Studio Early Arthritis) registry were prospectively analyzed to compare drug survival rates and the baseline factors that may predict adherence to therapy.Results.In 2003 and 2004, 324 patients started treatment with adalimumab, 311 with etanercept, and 218 with infliximab. After 4 years, the global retention rate of anti-TNF-α therapy was 42%. Etanercept survival (51.4%) …

MaleTime FactorsHealth StatusArthritisKaplan-Meier EstimateReceptors Tumor Necrosis FactorEtanerceptlaw.inventionEtanerceptArthritis RheumatoidRandomized controlled triallawRheumatoidMonoclonalReceptorsImmunology and AllergyProspective StudiesRegistriesskin and connective tissue diseasesProspective cohort studyHumanizedAntibodies Monoclonal; Antibodies Monoclonal Humanized; Antirheumatic Agents; Arthralgia; Arthritis Rheumatoid; Biological Markers; Drug Substitution; Female; Health Status; Humans; Immunoglobulin G; Italy; Joints; Kaplan-Meier Estimate; Male; Middle Aged; Pain Measurement; Prospective Studies; Receptors Tumor Necrosis Factor; Survival Rate; Time Factors; Tumor Necrosis Factor-alpha; RegistriesPain MeasurementDrug SubstitutionAntibodies MonoclonalMiddle AgedArthralgiaAdalimumab; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Antirheumatic Agents; Arthralgia; Arthritis Rheumatoid; Biomarkers; Drug Substitution; Etanercept; Female; Health Status; Humans; Immunoglobulin G; Infliximab; Italy; Joints; Kaplan-Meier Estimate; Male; Middle Aged; Pain Measurement; Prospective Studies; Receptors Tumor Necrosis Factor; Survival Rate; Time Factors; Tumor Necrosis Factor-alpha; RegistriesSurvival RateItalyRheumatoid arthritisAntirheumatic AgentsBiological MarkersAdalimumab; Drug survival; Etanercept; Infliximab; Adalimumab; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Antirheumatic Agents; Arthralgia; Arthritis Rheumatoid; Biomarkers; Drug Substitution; Etanercept; Female; Health Status; Humans; Immunoglobulin G; Infliximab; Italy; Joints; Kaplan-Meier Estimate; Male; Middle Aged; Pain Measurement; Prospective Studies; Receptors Tumor Necrosis Factor; Survival Rate; Time Factors; Tumor Necrosis Factor-alpha; Registries; Rheumatology; Immunology; Immunology and AllergyFemalemedicine.drugmusculoskeletal diseasesmedicine.medical_specialtyImmunologyAntibodies Monoclonal HumanizedAntibodiesRheumatologyDrug survivalInternal medicineAdalimumabmedicineHumansSurvival ratebusiness.industryTumor Necrosis Factor-alphaArthritisAdalimumabmedicine.diseaseInfliximabInfliximabSurgeryImmunoglobulin GJointsbusinessTumor Necrosis FactorBiomarkers
researchProduct

A case of naturally evolving gout in an elderly man

2012

Gout is a common disorder in adults that can lead to severe organ decline, disability and impaired quality of life due to the formation of periarticular tophi. We report a case of massive tophaceous gout in a 78-year-old man with a 16-year-long history of untreated disease. The patient gradually became disabled, his renal function deteriorated, and he finally died of sepsis. Our case demonstrates that chronic gout not only affects the joints, but is also associated with organ function decline and can, even nowadays, lead to death. © 2011 Elsevier Ireland Ltd.

Malemusculoskeletal diseasesAgingPediatricsmedicine.medical_specialtyHealth (social science)GoutAllopurinolOrgan functionDiseaseTophaceous gout in elderly Renal failure Sepsis HyperuricemiaMethylprednisoloneSeverity of Illness IndexGout SuppressantsTophaceous goutSepsisFatal OutcomeQuality of lifeRenal DialysisChronic goutSepsismedicineHumansHyperuricemiaMobility LimitationAgedbusiness.industryAcute Kidney Injurymedicine.diseaseArthralgiaAnti-Bacterial AgentsGoutSurgeryChronic DiseaseQuality of LifeDrug Therapy CombinationGeriatrics and GerontologyColchicineRespiratory InsufficiencybusinessGerontology
researchProduct